A case of endobronchial actinomycosis as a challenging cause of lung atelectasis.
Bronchoscopy
Endobronchial actinomycosis
Endoscopic treatment
Lung atelectasis
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
08 May 2021
08 May 2021
Historique:
received:
08
12
2020
accepted:
29
04
2021
entrez:
9
5
2021
pubmed:
10
5
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Primary endobronchial actinomycosis is exceptionally uncommon and can be misdiagnosed as unresolving pneumonia, endobronchial lipoma, bronchogenic carcinoma or foreign body. Predisposing factors are immunosuppressive conditions, chronic lung diseases, poor oral hygiene or foreign body aspiration. We reported a case of 88-year old woman with a 4 days history of mild exertional dyspnea, productive cough with purulent sputum and fever up to 37.8 °C, who developed left sided endobronchial actinomycosis in absence of any pre-existent risk conditions; endobronchial de-obstruction and specific antibiotic treatment were performed with success, achieving a full resolution of the disease, with bronchoscopy playing a key role in the diagnosticand therapeutic pathways. This case raises the necessity for increased awareness in the management of endobronchial lesions and in cases of suspected endobronchial actinomycosis; bronchoscopy plays a key role in the diagnostic and therapeutic process; prompt recognition of this entity can expedite proper treatment and recovery.
Sections du résumé
BACKGROUND
BACKGROUND
Primary endobronchial actinomycosis is exceptionally uncommon and can be misdiagnosed as unresolving pneumonia, endobronchial lipoma, bronchogenic carcinoma or foreign body. Predisposing factors are immunosuppressive conditions, chronic lung diseases, poor oral hygiene or foreign body aspiration.
CASE PRESENTATION
METHODS
We reported a case of 88-year old woman with a 4 days history of mild exertional dyspnea, productive cough with purulent sputum and fever up to 37.8 °C, who developed left sided endobronchial actinomycosis in absence of any pre-existent risk conditions; endobronchial de-obstruction and specific antibiotic treatment were performed with success, achieving a full resolution of the disease, with bronchoscopy playing a key role in the diagnosticand therapeutic pathways.
CONCLUSIONS
CONCLUSIONS
This case raises the necessity for increased awareness in the management of endobronchial lesions and in cases of suspected endobronchial actinomycosis; bronchoscopy plays a key role in the diagnostic and therapeutic process; prompt recognition of this entity can expedite proper treatment and recovery.
Identifiants
pubmed: 33964874
doi: 10.1186/s12879-021-06126-3
pii: 10.1186/s12879-021-06126-3
pmc: PMC8105992
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
433Références
Infect Drug Resist. 2014 Jul 05;7:183-97
pubmed: 25045274
Tanaffos. 2014;13(1):52-6
pubmed: 25191495
BMC Infect Dis. 2013 May 14;13:216
pubmed: 23672372
Eur Respir J. 2003 Mar;21(3):545-51
pubmed: 12662015
Mayo Clin Proc. 2009 Feb;84(2):123-8
pubmed: 19181645
Laryngoscope. 1984 Sep;94(9):1198-217
pubmed: 6381942
AJR Am J Roentgenol. 2006 Jan;186(1):225-31
pubmed: 16357406
Korean J Intern Med. 2000 Dec;15(3):240-4
pubmed: 11242814
BMJ. 2011 Oct 11;343:d6099
pubmed: 21990282
J Comput Assist Tomogr. 2020 Sep/Oct;44(5):656-666
pubmed: 32842067
Clin Infect Dis. 2004 Feb 1;38(3):444-7
pubmed: 14727221
Lung India. 2015 Nov-Dec;32(6):651-4
pubmed: 26664183